hA20 (Veltuzumab)

veltuzumab · Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hA20 (Veltuzumab), covering 2021-08-18 to 2021-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma [Phase 1, Phase 2]